Position in FTRE
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$6,771,297
+$3,878,453 QoQ
Shares Held
389,155
+26.7% QoQ
Ownership
0.409%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#40
of 331 holders
Holding Since
Sep 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FTRE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WINTON GROUP Ltd holds $97,029,578 across 91 Biotechnology names. FTRE ranks #2 (7.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
254,408 | $28,839,690 | |
| 2 | FTRE |
Fortrea Holdings Inc.
This page
|
389,155 | $6,771,297 | |
| 3 | EXEL |
Exelixis, Inc.
|
99,834 | $5,431,967 | |
| 4 | TECH |
BIO-TECHNE Corp
|
67,227 | $4,749,587 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
60,348 | $4,723,437 | |
| 6 | VKTX |
Viking Therapeutics, Inc.
|
90,546 | $3,532,199 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
7,880 | $2,372,116 | |
| 8 | TRVI |
Trevi Therapeutics, Inc.
|
106,852 | $1,992,789 |
All Filings in FTRE
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,771,297 | 389,155 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $2,892,844 | 307,096 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $4,820,633 | 279,457 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $2,565,355 | 304,674 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $51,366 | 10,398 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $980,382 | 129,852 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,133,882 | 60,798 | Shares | Sole | 2025-02-12 | |
| 2024-03-31 | $1,149,489 | 28,637 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $516,136 | 14,789 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $422,245 | 14,769 | Shares | Sole | 2023-11-13 | |
| No filing history on record for this holder in this stock. | ||||||